Cutaneous sporotrichoid leishmaniasis treated with oral fluconazole
Corresponding Author
Michael Benzaquen
Aix Marseille University, APHM, Hôpital Nord, Department of Dermatology, Marseille, France
Correspondence
Michael Benzaquen, Aix Marseille University, APHM, Hôpital Nord, Department of Dermatology, Chemin des Bourrely, 13015 Marseille, France.
Email: [email protected]
Search for more papers by this authorAudrey Chambelland
Aix Marseille University, APHM, Hôpital Nord, Department of Dermatology, Marseille, France
Search for more papers by this authorJessica Fongue
Aix Marseille University, APHM, Hôpital Nord, Department of Dermatology, Marseille, France
Search for more papers by this authorCléa Melenotte
Aix Marseille University, IRD, APHM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France
Search for more papers by this authorJacques-Robert Christen
Aix Marseille University, IRD, APHM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France
Search for more papers by this authorStéphane Ranque
Aix Marseille University, IRD, APHM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France
Search for more papers by this authorJean-Pascal Buono
Aix Marseille University, APHM, Hôpital Nord, Department of Anatomical and Cellular Pathology, Marseille, France
Search for more papers by this authorPhilippe Parola
Aix Marseille University, IRD, APHM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France
Search for more papers by this authorPhilippe Berbis
Aix Marseille University, APHM, Hôpital Nord, Department of Dermatology, Marseille, France
Search for more papers by this authorCorresponding Author
Michael Benzaquen
Aix Marseille University, APHM, Hôpital Nord, Department of Dermatology, Marseille, France
Correspondence
Michael Benzaquen, Aix Marseille University, APHM, Hôpital Nord, Department of Dermatology, Chemin des Bourrely, 13015 Marseille, France.
Email: [email protected]
Search for more papers by this authorAudrey Chambelland
Aix Marseille University, APHM, Hôpital Nord, Department of Dermatology, Marseille, France
Search for more papers by this authorJessica Fongue
Aix Marseille University, APHM, Hôpital Nord, Department of Dermatology, Marseille, France
Search for more papers by this authorCléa Melenotte
Aix Marseille University, IRD, APHM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France
Search for more papers by this authorJacques-Robert Christen
Aix Marseille University, IRD, APHM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France
Search for more papers by this authorStéphane Ranque
Aix Marseille University, IRD, APHM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France
Search for more papers by this authorJean-Pascal Buono
Aix Marseille University, APHM, Hôpital Nord, Department of Anatomical and Cellular Pathology, Marseille, France
Search for more papers by this authorPhilippe Parola
Aix Marseille University, IRD, APHM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France
Search for more papers by this authorPhilippe Berbis
Aix Marseille University, APHM, Hôpital Nord, Department of Dermatology, Marseille, France
Search for more papers by this author
REFERENCES
- Aronson, N., Herwaldt, B. L., Libman, M., Pearson, R., Lopez-Velez, R., Weina, P., … Magill, A. (2016). Diagnosis and treatment of leishmaniasis: Clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clinical Infectious Diseases, 63, e202–e264.
- Emad, M., Hayati, F., Fallahzadeh, M. K., & Namazi, M. R. (2011). Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous Leishmania major infection: A randomized clinical trial. Journal of the American Academy of Dermatology, 64, 606–608.
- Heras-Mosteiro, J., Monge-Maillo, B., Pinart, M., Lopez Pereira, P., Reveiz, L., Garcia-Carrasco, E., … López-Vélez, R. (2017). Interventions for Old World cutaneous leishmaniasis (review). Cochrane Database of Systematic Reviews, 12, CD005067. https://doi.org/10.1002/14651858.CD005067
- Hodiamont, C. J., Kager, P. A., Bart, A., de Vries, H. J. C., van Thiel, P. P. A. M., Leenstra, T., … van Gool, T. (2014). Species-directed therapy for leishmaniasis in returning travellers: A comprehensive guide. PLoS Neglected Tropical Diseases, 8, e2832.
- Karimkhani, C., Wanga, V., Coffeng, L. E., Naghavi, P., Dellavalle, R. P., & Naghavi, M. (2016). Global burden of cutaneous leishmaniasis: A cross-sectional analysis from the global burden of disease study 2013. The Lancet Infectious Diseases, 16, 584–591.
- Mary, C., Faraut, F., Lascombe, L., & Dumon, H. (2004). Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. Journal of Clinical Microbiology, 42, 5249–5255.
- Mosimann, V., Blazek, C., Grob, H., Chaney, M., Neumayr, A., & Blum, J. (2016). Miltefosine for mucosal and complicated cutaneous Old World leishmaniasis: A case series and review of the literature. Open Forum Infectious Diseases, 3, ofw008.
- Solomon, M., Greenberger, S., Baum, S., Pavlotsky, F., Barzilai, A., & Schwartz, E. (2016). Unusual forms of cutaneous leishmaniasis due to Leishmania major. Journal of the European Academy of Dermatology and Venereology, 30, 1171–1175.
- Wall, E. C., Watson, J., Armstrong, M., Chiodini, P. L., & Lockwood, D. N. (2012). Epidemiology of imported cutaneous leishmaniasis at the Hospital for Tropical Diseases, London, United Kingdom: Use of polymerase chain reaction to identify the species. The American Journal of Tropical Medicine and Hygiene, 86, 115–118.
